Involvement of the Peroxisome Proliferator-Activated Receptor Alpha in the Immunomodulation Caused by Peroxisome Proliferators in Mice
Abstract
Peroxisome proliferators (PPs) are a large class of structurally diverse chemicals, which includes drugs designed to improve the metabolic abnormalities linking hypertriglyceridemia to diabetes, hyperglycemia, insulin-resistance and atherosclerosis. We have recently demonstrated that exposure of rodents to potent PPs indirectly causes a number of immunomodulating effects, resulting in severe adaptive immunosuppression. Since the peroxisome proliferator-activated receptor alpha (PPARalpha) plays a central role in mediating the pleiotropic responses exerted by PPs, we have compared here the immunomodulating effects of the PPs perfluorooctanoic acid (PFOA) and Wy-14,643 in wild-type and PPARalpha-null mice. The reductions in spleen weight and in the number of splenocytes caused by PP treatment in wild-type mice was not observed in PPARalpha-null mice. Furthermore, the reductions in thymus weight and in the number of thymocytes were potently attenuated in the latter animals. Similarly, the dramatic decreases in the size of the CD4(+)CD8(+) population of cells in the thymus and in the number of thymocytes in the S and G2/M phases of the cell cycle observed in wild-type mice administered PPs were much less extensive in PPARalpha-null mice. Finally, in contrast to the case of wild-type animals, the response of splenocytes isolated from the spleen of PP-treated PPARalpha-null mice to appropriate T- or B-cell activators in vitro was not reduced. Altogether, these data indicate that PPARalpha plays a major role in the immunomodulation caused by PPs. The possible relevance of these changes to the alterations in plasma lipids also caused by PPs is discussed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PPARα plays a significant role in the immunomodulation induced by PFOA and other peroxisome proliferators.
“These findings highlight the significant role of PPARα in the immunomodulation induced by PFOA and other peroxisome proliferators [37].”
From The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science (2023) · cites this paper as [37]
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,580 · see citing works
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110 · see citing works
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217 · see citing works
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,941 · see citing works
Lee, S. S. T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernández‐Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655 · see citing works
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · see citing works
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943 · see citing works
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863 · see citing works
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 704 · see citing works
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 484 · see citing works
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Escher, P., Braissant, O., Modak, S. B., Michalik, L., Wahli, W., & Desvergne, B. (2001) · Endocrinology · doi:10.1210/endo.142.10.8458 · Cited by 473 · see citing works
Staels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117717 · Cited by 410 · see citing works
Corton, J. C., Anderson, S. P., & Stauber, A. J. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.491 · Cited by 341 · see citing works
Ward, J. M., Peters, J. M., Perella, C. M., & Gonzalez, F. J. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600208 · Cited by 249 · see citing works
Metabolism in lymphocytes and its importance in the immune response.
Ardawi, M. S., & Newsholme, E. A. (1985) · PubMed · Cited by 231 · see citing works
Cell-mediated immunity in atherosclerosis
Hansson, G. K. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00009 · Cited by 171 · see citing works
Yang, Q., Abedi‐Valugerdi, M., Xie, Y., Zhao, X., Möller, G., Nelson, B. D., & DePierre, J. W. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00164-3 · Cited by 169 · see citing works
Self-citationImmunotoxicity of pesticides: a review
Blakley, B. R., Brousseau, P., Fournier, M., & Voccia, I. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500110 · Cited by 166 · see citing works
Ikeda, T., Aiba, K., FUKUDA, K., & Tanaka, M. (1985) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135302 · Cited by 165 · see citing works
Auwerx, J. H., Schoonjans, K., Fruchart, J., & Staels, B. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05854-6 · Cited by 158 · see citing works
Effects of peroxisome proliferators on the thymus and spleen of mice
Yang, Q., Xie, Y., & DePierre, J. W. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01367.x · Cited by 143 · see citing works
Self-citationYang, Q., Xie, Y., Eriksson, A. M., Nelson, B. D., & DePierre, J. W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00752-3 · Cited by 115 · see citing works
Self-citationMembrane compartmentation and the response to antigen
Xavier, R. J., & Seed, B. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80043-0 · Cited by 110 · see citing works
Immunotoxicity of pesticides: a review
Voccia, I., Blakley, B., Brousseau, P., et al. (1999) · Toxicology and Industrial Health · doi:10.1191/074823399678846637 · Cited by 104 · see citing works
Chemical agents and the immune response.
Luster, M. I., & Rosenthal, G. J. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93100219 · Cited by 101 · see citing works
Poosch, M. S., & Yamazaki, R. K. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90211-4 · Cited by 99 · see citing works
Jiang, Y., & Möller, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3138 · Cited by 87 · see citing works
Roberts, R. A. (1999) · Archives of Toxicology · doi:10.1007/s002040050629 · Cited by 74 · see citing works
Disposition of perfluorodecanoic acid in male and female rats
Heuvel, J. P. V., Kuslikis, B. I., Rafelghem, M. J. V., & Peterson, R. E. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90308-2 · Cited by 65 · see citing works
Cuthbert, J. A., & Lipsky, P. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35692-2 · Cited by 58 · see citing works
Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis
Lake, B. G. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03513-3 · Cited by 51 · see citing works
Nix, M., & Stoffel, W. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400666 · Cited by 51 · see citing works
Sohlenius, A., Lundgren, B., & DePierre, J. W. (1992) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570070403 · Cited by 49 · see citing works
Self-citationIntroduction To Immunotoxicology
Descotes, J. (1998) · CRC Press eBooks · doi:10.1201/9781482295221 · Cited by 49 · see citing works
Cuthbert, J. A., & Lipsky, P. E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80020-5 · Cited by 44 · see citing works
Introduction to Immunotoxicology
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46810-7_1 · Cited by 42 · see citing works
Okochi, E., Nishimaki‐Mogami, T., Suzuki, K., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00024-4 · Cited by 24 · see citing works
Fiedler, J., Simon, F. R., Iwahashi, M., & Murphy, R. C. (2001) · PubMed · Cited by 20 · see citing works
The Role of Cholesterol and Its Biosynthesis in Lymphocyte Proliferation and Differentiationa
Heiniger, H., Chen, H. W., Boissonneault, G. A., et al. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb20820.x · Cited by 10 · see citing works
Herzberg, V. L. (1991) · Immunological Investigations · doi:10.3109/08820139109082631 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742 · see citing works
Toxicology of perfluorinated compounds
Stahl, T., Mattern, D., & Brunn, H. (2011) · Environmental Sciences Europe · doi:10.1186/2190-4715-23-38 · Cited by 432 · see citing works
TOXICITY AND TOXICOKINETICS OF PERFLUOROOCTANOIC ACID IN HUMANS AND ANIMALS
KUDO, N., & KAWASHIMA, Y. (2003) · The Journal of Toxicological Sciences · doi:10.2131/jts.28.49 · Cited by 392 · see citing works
Hines, E. P., White, S. S., Stanko, J. P., Gibbs-Flournoy, E. A., Lau, C., & Fenton, S. E. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.021 · Cited by 282 · see citing works
Risk Assessment of Per- and Polyfluoroalkyl Substance Mixtures: A Relative Potency Factor Approach
Bil, W., Zeilmaker, M., Fragki, S., Lijzen, J., Verbruggen, E., & Bokkers, B. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4835 · Cited by 158 · see citing works
Borg, D., Lund, B.-O., Lindquist, N.-G., & Håkansson, H. (2013) · Environment International · doi:10.1016/j.envint.2013.05.009 · Cited by 155 · see citing works
Bjork, J. A., & Wallace, K. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp093 · Cited by 137 · see citing works
Rand, A. A., & Mabury, S. A. (2017) · Toxicology · doi:10.1016/j.tox.2016.11.011 · Cited by 92 · see citing works
The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science
Spyrakis, F., & Dragani, T. A. (2023) · Toxics · doi:10.3390/toxics11090721 · Cited by 78 · see citing works
More, V. R., Campos, C. R., Evans, R. A., Oliver, K. D., Chan, G. N., Miller, D. S., & Cannon, R. E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16650216 · Cited by 59 · see citing works
- Authors
- Yang, Q., Xie, Y., Alexson, S. E. H., Dean Nelson, B., & DePierre, J. W.
- Affiliations
- Stockholm University (SE)
- Karolinska Institutet (SE)
- Corresponding author
- Yang, Qian
- ORCID
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 63
- Issue
- 10
- Pages
- 1893-1900
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2034901755
- Cited by
- 131
- References
- 41
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 4 · 2014: 11 · 2013: 5 · 2012: 6
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Knut och Alice Wallenbergs Stiftelse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Keywords
- peroxisome proliferators, PPARα, immunomodulation, immunosuppression, perfluorooctanoic acid, Wy-14,643, PPARalpha-null mice, thymus, spleen, CD4+CD8+ thymocytes, T cell response, B cell response, plasma lipids, hypertriglyceridemia
- MeSH terms
- Adjuvants, Immunologic, Animals, Caprylates, Cell Cycle, Cell Division, Cells, Cultured, Fluorocarbons, Liver, Male, Mice, Inbred BALB C, Organ Size, Pyrimidines, Spleen, Thymus Gland, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Peroxisome Proliferators, Peroxisomes, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review